Urinary cotinine levels of electronic cigarette (e-cigarette) users.

Area of Science:

• Environmental Health
• Toxicology
• Public Health

Background:

• Electronic cigarette (e-cigarette) popularity is rising globally, yet scientific data on nicotine exposure is limited.
• Research on nicotine exposure often relies on analyzing urine samples from users.
• Understanding nicotine exposure is crucial for public health assessments of e-cigarette use.

Purpose of the Study:

• To quantify and compare nicotine exposure levels in e-cigarette users, cigarette smokers, and passive smokers.
• To investigate the extent of nicotine exposure associated with different forms of tobacco and e-cigarette consumption.
• To provide scientific evidence on the physiological impact of e-cigarette usage.

Main Methods:

• Urine samples were collected from four groups: e-cigarette users, cigarette smokers, passive smokers, and healthy non-smokers.
• Urinary cotinine levels, a biomarker of nicotine exposure, were measured using gas chromatography-mass spectrometry.
• Data analysis focused on comparing mean cotinine levels across the different participant groups.

Main Results:

• Mean urinary cotinine levels were 1755 ± 1848 ng/g creatinine for e-cigarette users and 1720 ± 1335 ng/g creatinine for cigarette smokers.
• Passive smokers exhibited significantly lower mean cotinine levels at 81.42 ± 97.90 ng/g creatinine.
• No statistically significant difference in cotinine levels was observed between e-cigarette users and cigarette smokers (p > 0.05).

Conclusions:

• E-cigarette users experience nicotine exposure levels similar to those of traditional cigarette smokers.
• A significant difference in nicotine exposure exists between e-cigarette users and passive smokers.
• This study provides seminal evidence confirming substantial nicotine exposure in e-cigarette users.